Originally published February 28 2005
Saliva may be able to predict some cancers
by Mike Adams, the Health Ranger, NaturalNews Editor
UCLA researchers have "promising" data from tests using saliva to screen for head and neck cancers. By testing saliva molecules, researchers were able to identify cancer in nine of ten instances. Due to the size of the study -- only sixty-four subjects -- the scientists say additional tests are needed to determine a realistic detection level. Experts in England say the new test could satisfy their a need for simple, non-invasive, speedy cancer detection methods
- Saliva tests could be used to detect tumors such as breast cancer, researchers believe.
- A small study on 32 patients with head and neck cancers showed promising results using a test that checks for genetic signs of cancer in saliva.
- The University of California Los Angeles researchers now plan a much larger study they told the journal Clinical Cancer Research.
- UK cancer experts said there was a need for simple, non-invasive cancer tests.
- Dr David Wong and his team at UCLA's Jonsson Comprehensive Cancer Center decided instead to look at the genetic messenger for such proteins, called RNA.
- They recruited 32 patients with cancers of the mouth, tongue and throat and 32 healthy volunteers of the same age and sex.
- "With a larger study, we will move that accuracy closer to 100%," he said.
- His team is currently recruiting 200 patients with oral cancer to this end.
- "We now hope to demonstrate the utility of saliva for systemic diagnosis of other diseases such as breast cancer," he added.
- Rates of oral cancer are increasing in the UK, especially among women and young adults, and the risk is highest for people who smoke and drink alcohol.
- Dr Kat Arney of Cancer Research UK said: "Early detection of cancer can greatly increase a person's chances of survival.
- "The use of RNA to detect cancer is a potential advance in technology, particularly using a non-invasive saliva test.
- "The UCLA team have produced some promising early results, and it will be important to see if this test proves to be reliable in a larger number of patients."
- Dr Nick Coleman from the Medical Research Council's Cancer Cell Unit in Cambridge, said: "It is a good type of approach to take.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml